Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609
- PMID: 7553223
- DOI: 10.1089/jir.1995.15.537
Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609
Abstract
Imiquimod (R-837) and its analog, S-27609, belong to a class of imidazoquinolinamines that have potent antitumor and antiviral effects in animals. Much of their biologic activity is a result of the induction of cytokines, including interferon-alpha (IFN-alpha), tumor necrosis factor alpha (TNF), and others. In this study, the cells responsible for S-27609- and imiquimod-induced cytokine production were characterized. E rosette+ T cells were not the major cell population responsible for IFN-alpha and TNF in response to S-27609 or imiquimod. In contrast, E rosette- cells and unseparated PBMC produced similar concentrations of IFN-alpha and TNF in response to S-27609 and imiquimod. Elimination of monocytes by treatment with the lysosomotropic agent L-leucine methyl ester (LME) or depletion using antibody to CD14 and immunomagnetic beads abrogated IFN-alpha and TNF production induced by S-27609, imiquimod, or LPS but not poly(I)/(C). LME treatment also abolished interleukin (IL)-1 alpha, IL-beta, IL-6, and IL-8 production stimulated by S-27609 and imiquimod. Removal of HLA-DR+ or CD36+ monocytes also caused a significant reduction in S-27609- and imiquimod-induced IFN-alpha and TNF. Elimination of B cells, NK cells, and dendritic cells did not significantly reduce cytokine induction in response to S-27609. Thus, the cell population responsible for the majority of cytokine release in human PBMC in response to S-27609 and imiquimod is a E rosette-, CD14+, CD36+, HLA-DR+ monocyte.
Similar articles
-
Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463.Cytokine. 1997 Nov;9(11):837-45. doi: 10.1006/cyto.1997.0239. Cytokine. 1997. PMID: 9367544
-
Cytokine induction by the immunomodulators imiquimod and S-27609.J Leukoc Biol. 1995 Sep;58(3):365-72. doi: 10.1002/jlb.58.3.365. J Leukoc Biol. 1995. PMID: 7665993
-
Cytokine induction in mice by the immunomodulator imiquimod.J Leukoc Biol. 1994 Feb;55(2):234-40. doi: 10.1002/jlb.55.2.234. J Leukoc Biol. 1994. PMID: 7507969
-
Imiquimod applied topically: a novel immune response modifier and new class of drug.Int J Immunopharmacol. 1999 Jan;21(1):1-14. doi: 10.1016/s0192-0561(98)00068-x. Int J Immunopharmacol. 1999. PMID: 10411278 Review.
-
Immunomodulatory and pharmacologic properties of imiquimod.J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S6-11. doi: 10.1067/mjd.2000.107808. J Am Acad Dermatol. 2000. PMID: 10861101 Review.
Cited by
-
Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.Int J Biol Macromol. 2020 Nov 15;163:1-8. doi: 10.1016/j.ijbiomac.2020.06.228. Epub 2020 Jun 26. Int J Biol Macromol. 2020. PMID: 32599245 Free PMC article.
-
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.J Invest Dermatol. 2009 Nov;129(11):2676-85. doi: 10.1038/jid.2009.151. Epub 2009 Jun 11. J Invest Dermatol. 2009. PMID: 19516264 Free PMC article.
-
The Micro-Immunotherapy Medicine 2LPAPI® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells.Cancers (Basel). 2024 Apr 5;16(7):1421. doi: 10.3390/cancers16071421. Cancers (Basel). 2024. PMID: 38611099 Free PMC article.
-
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.Environ Res. 2020 Sep;188:109858. doi: 10.1016/j.envres.2020.109858. Epub 2020 Jun 23. Environ Res. 2020. PMID: 32846644 Free PMC article.
-
Topical imiquimod: a review of its use in genital warts.Drugs. 1999 Aug;58(2):375-90. doi: 10.2165/00003495-199958020-00017. Drugs. 1999. PMID: 10473026 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials